Search results for "MicroRNA"

showing 10 items of 577 documents

Hsa-miR-30d, secreted by the human endometrium, is taken up by the pre-implantation embryo and might modify its transcriptome.

2015

During embryo implantation, the blastocyst interacts with and regulates the endometrium, and endometrial fluid secreted by the endometrial epithelium nurtures the embryo. Here, we propose that maternal microRNAs (miRNAs) might act as transcriptomic modifier of the pre-implantation embryo. Microarray profiling revealed that six of 27 specific, maternal miRNAs were differentially expressed in the human endometrial epithelium during the window of implantation – a brief phase of endometrial receptivity to the blastocyst – and were released into the endometrial fluid. Further investigation revealed that hsa-miR-30d, the expression levels of which were most significantly upregulated, was secreted…

Endometrial fluidanimal structuresBlotting WesternEmbryonic DevelopmentBiologyEndometriumPolymerase Chain ReactionTranscriptomeEndometriumMiceMicroscopy Electron TransmissionmicroRNAmedicineAnimalsHumansBlastocystMolecular BiologyEmbryo adhesionPre-implantation embryoMicroarray analysis techniquesEmbryogenesisGene Expression Regulation DevelopmentalEmbryoMicroarray AnalysisMolecular biologyEmbryonic stem cellImmunohistochemistryCell biologyHas-miR-30dMicroRNAsmedicine.anatomical_structureBlastocystMicroscopy Fluorescenceembryonic structuresFemaleTranscriptomeDevelopmental BiologyDevelopment (Cambridge, England)
researchProduct

Membrane-bound exosomal HSP70 as a biomarker for detection and monitoring of malignant solid tumours: a pilot study

2019

Abstract Background Cancer is the second leading cause of death globally. Early detection and disease management lead to a better survival rate. Consequently, discovery of novel methods in cancer early diagnosis is a field of active research. Minimally invasive liquid biopsies are generating growing interest. Circulating tumour cells (CTCs) have been identified in patients’ blood; nevertheless, these cells are rare and heterogeneous. Exosomes are extracellular nanovesicles released into the extracellular environment via the endosomal vesicle pathway and found in different body fluids. Exosomes deliver bioactive cargo such as proteins, mRNA and miRNA to recipient cells in the tumour environm…

EndosomeMedicine (miscellaneous)HSP70-exosomesStudy Protocol03 medical and health sciences0302 clinical medicinemicroRNAmedicineLiquid biopsySurvival rate030304 developmental biologyPilot studySolid tumours0303 health scienceslcsh:R5-920Liquid biopsyCancer diagnosis and monitoringbusiness.industryCancermedicine.diseaseMicrovesicles3. Good healthBiomarker (cell)030220 oncology & carcinogenesisCancer cellCancer researchbusinesslcsh:Medicine (General)Pilot and Feasibility Studies
researchProduct

Non-coding RNAs and Coronary Artery Disease

2020

Coronary artery disease (CAD) is the leading death cause worldwide. Non-coding RNA (ncRNA) are key regulators of genetic expression and thus can affect directly or indirectly the development and progression of different diseases. ncRNA can be classified in several types depending on the length or structure, as long non-coding RNA (lncRNA), microRNA (miRNA) and circularRNA (circRNA), among others. These types of RNA are present within cells or in circulation, and for this reason they have been used as biomarkers of different diseases, therefore revolutionizing precision medicine. Recent research studied the capability of circulating ncRNA to inform about CAD presence and predict the outcome …

Enfermedad cardiovascularRNABiomarkerDiseaseComputational biologyGenética humanaBiologyNon-coding RNAPrecision medicinemedicine.diseaseARNCoronary artery disease (CAD)Coronary artery disease03 medical and health scienceslncRNA0302 clinical medicineBiomarker; Coronary artery disease (CAD); circRNA; lncRNA; miRNAGene expressionmicroRNAmedicineBiomarker (medicine)Cardiopatía coronariacircRNA030212 general & internal medicinemiRNA
researchProduct

Epigenetic biomarkers for disease diagnosis

2019

Abstract Epigenetic dysregulation plays an important role in the initiation and progression of human diseases; therefore, because of the dynamic nature of this orchestrated regulation of epigenetic marks and epigenetic mechanisms, it is possible to use these marks as biomarkers. In this context, an epigenetic biomarker is “any epigenetic mark or altered epigenetic mechanism” which generally serves to evaluate health or disease status, progression or treatment response and is particularly stable and reproducible during sample processing. Advances in precision medicine, with better diagnostic and treatment strategies are the hope to improve the management of diseases, comorbidities, and morta…

Epigenetic biomarkersbusiness.industrymicroRNADNA methylationBiomarker (medicine)MedicineContext (language use)EpigeneticsDiseasePrecision medicineBioinformaticsbusiness
researchProduct

Clinical and immunological aspects of microRNAs in neonatal sepsis

2022

Abstract Neonatal sepsis constitutes a highly relevant public health challenge and is the most common cause of infant morbidity and mortality worldwide. Recent studies have demonstrated that during infection epigenetic changes may occur leading to reprogramming of gene expression. Post-transcriptional regulation by short non-coding RNAs (e.g., microRNAs) have recently acquired special relevance because of their role in the regulation of the pathophysiology of sepsis and their potential clinical use as biomarkers. ~22-nucleotide of microRNAs are not only involved in regulating multiple relevant cellular and molecular functions, such as immune cell function and inflammatory response, but have…

Epigenetic changesInflammationRM1-950BioinformaticsEpigenesis GeneticSepsisImmune systemInfant morbiditymicroRNAmedicineAnimalsHumansEpigeneticsInflammationPharmacologyNeonatal sepsisbusiness.industryInfant NewbornImmunityGeneral MedicinePrognosismedicine.diseaseMicroRNAsGene Expression RegulationNeonatal sepsisTherapeutics. Pharmacologymedicine.symptombusinessReprogrammingBiomarkersBiomedicine & Pharmacotherapy
researchProduct

Epigenetic biomarkers: A new perspective in laboratory diagnostics.

2012

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare…

EpigenomicsClinical BiochemistryBiologyBiochemistryEpigenesis GeneticHistonesmicroRNACancer; DNA methylation; Histone; MiRNAs; Rare disease;HumansEpigeneticsPathology MolecularEpigenesisEpigenomicsCancerGeneticsEpigenetic biomarkersBiochemistry (medical)Nuclear organizationGeneral MedicineSequence Analysis DNADNA MethylationHistoneMicroRNAsHistoneDNA methylationbiology.proteinMiRNAsRare diseaseProtein Processing Post-TranslationalBiomarkersClinica chimica acta; international journal of clinical chemistry
researchProduct

Science and Healthy Meals in the World: Nutritional Epigenomics and Nutrigenetics of the Mediterranean Diet

2020

The Mediterranean Diet (MD), UNESCO Intangible Cultural Heritage of Humanity, has become a scientific topic of high interest due to its health benefits. The aim of this review is to pick up selected studies that report nutrigenomic or nutrigenetic data and recapitulate some of the biochemical/genomic/genetic aspects involved in the positive health effects of the MD. These include (i) the antioxidative potential of its constituents with protective effects against several diseases; (ii) the epigenetic and epigenomic effects exerted by food components, such as Indacaxanthin, Sulforaphane, and 3-Hydroxytyrosol among others, and their involvement in the modulation of miRNA expression; (iii) the …

EpigenomicsMale0301 basic medicineIntangible cultural heritageMediterranean dietHealth StatusGene Expressionlcsh:TX341-641030209 endocrinology & metabolismReviewnutrigenomicHealth benefitsBiologyDiet MediterraneanXanthineAntioxidantsNutrigeneticsEating03 medical and health sciences0302 clinical medicinenutrigenomicsIsothiocyanatesSettore BIO/10 - BiochimicaMediterranean dietEnvironmental healthHumansFood componentsSettore BIO/06 - Anatomia Comparata E CitologianutrigeneticsEpigenomics030109 nutrition & dieteticsNutrition and DieteticsCooking methodsPhenylethyl AlcoholMicroRNAsSettore BIO/18 - GeneticaNutrigenomicsNutrigeneticSulfoxidesFemaleDiet Healthylcsh:Nutrition. Foods and food supplyFood AnalysisFood ScienceNutrients
researchProduct

Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion

2022

Osteosarcoma (OS) is the most common primary bone tumor mainly occurring in young adults and derived from primitive bone-forming mesenchyme. OS develops in an intricate tumor microenvironment (TME) where cellular function regulated by microRNAs (miRNAs) may affect communication between OS cells and the surrounding TME. Therefore, miRNAs are considered potential therapeutic targets in cancer and one of the goals of research is to accurately define a specific signature of a miRNAs, which could reflect the phenotype of a particular tumor, such as OS. Through NGS approach, we previously found a specific molecular profile of miRNAs in OS and discovered 8 novel miRNAs. Among these, we deepen our …

Epithelial-Mesenchymal TransitionQH301-705.5MAP Kinase Signaling SystemEMT proteinBone NeoplasmsArticleCatalysisCell LineInorganic ChemistryCell Line TumorHuman Umbilical Vein Endothelial CellsmetastasisHumansNeoplasm InvasivenessBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyOsteosarcomaOsteoblastsmicroRNANeovascularization PathologicOrganic ChemistryEMT proteinstumor angiogenesisGeneral MedicinemicroRNAsComputer Science ApplicationsGene Expression Regulation NeoplasticChemistryosteosarcoma; microRNAs; tumor angiogenesis; metastasis; EMT proteinsmetastasitumor angiogenesiInternational Journal of Molecular Sciences
researchProduct

Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer

2015

Metastasis is the main cause of cancer mortality. One of the initiating events of cancer metastasis of epithelial tumors is epithelial-to-mesenchymal transition (EMT), during which cells dedifferentiate from a relatively rigid cell structure/morphology to a flexible and changeable structure/morphology often associated with mesenchymal cells. The presence of EMT in human epithelial tumors is reflected by the increased expression of genes and levels of proteins that are preferentially present in mesenchymal cells. The combined presence of these genes forms the basis of mesenchymal gene signatures, which are the foundation for classifying a mesenchymal subtype of tumors. Indeed, tumor classifi…

Epithelial-Mesenchymal TransitionReviewBiologyBioinformaticsMetastasis03 medical and health sciences0302 clinical medicinemicroRNAGene expressionmedicineHumanscancerEpithelial–mesenchymal transitionCystadenocarcinomaGene030304 developmental biologyOvarian Neoplasms0303 health sciencesMessenger RNAmiR-506Mesenchymal stem cellmiR-101medicine.diseaseCystadenocarcinoma Serous3. Good healthMicroRNAsOncology030220 oncology & carcinogenesisCancer researchFemaleovaryMicroRNA (miRNA)epithelial-to-mesenchymal transition (EMT)Chinese Journal of Cancer
researchProduct

MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.

2020

BACKGROUND/AIM MicroRNAs (miRNAs) regulate the development of colorectal cancer (CRC). We aimed to investigate miRNAs and their relation to cancer-related signaling pathways in site-specific CRC. MATERIALS AND METHODS We used a total of 24 left- and right-sided Finnish CRC samples (discovery cohort) and The Cancer Genome Atlas public mature miRSeq dataset of 201 CRC samples (validation cohort). MiRNA differential expression and biological pathway analyses were performed using DESeq2 and the DIANA/mirPath tool, respectively. RESULTS We found 17 significantly differentially up-regulated [false discovery rate (FDR) <0.05] miRNAs in left-sided CRC ("left miRNAs"), and 15 in right-sided CRC ("ri…

False discovery rateOncologyMaleCancer Researchmedicine.medical_specialtyColorectal cancerDown-RegulationBiological pathwayCohort StudiesPhosphatidylinositol 3-KinasesTransforming Growth Factor betaInternal medicinemicroRNAMedicineHumansDifferential expressionPI3K/AKT/mTOR pathwayAgedbusiness.industryWnt signaling pathwayGeneral Medicinemedicine.diseasedigestive system diseasesUp-RegulationGene Expression Regulation NeoplasticOncologyCohortFemalebusinessColorectal NeoplasmsProto-Oncogene Proteins c-aktSignal TransductionAnticancer research
researchProduct